Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
upgraded at BMO from Underperform to Market Perform. Valuation call.
estimates, target upped at UBS. ALTR estimates were boosted through 2012, UBS said. Company guided to higher sales and margins. Buy rating and new $42.50 price target.
downgraded at Collins Stewart to Hold from Buy. Valuation call.
upgraded at Wells from Market Perform to Outperform. Company has improved earnings visibility.
upgraded at RBC from Sector Perform to Outperform. $66 price target. Valuation call, as the company can return to double-digit annual earnings growth.
upgraded at Jefferies from Hold to Buy. $67 price target. Margins should improve as the company's volume recovery accelerates.
upgraded at BMO from Market Perform to Outperform. Valuation call. $27 price target.
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $50 price target.
downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. $110 price target.
rated new Outperform at RBC. Coverage of SMG was started with an Outperform rating, RBC Capital said. $60 price target. Company can generate solid cash flow over the coming years.
rated new Equal-weight at Morgan Stanley. Stock is already pricing in the upcoming business cycle.
rated new Outperform at Baird. $18 price target. Company has significant earnings potential in the current cycle.
( TLAB) estimates, target lowered at Goldman. Shares of TLAB now seen reaching $6, according to Goldman Sachs. Estimates also reduced, as the company is losing market share to ALU. Neutral rating.
upgraded at BMO from Underperform to Outperform, BMO Capital said. Company has attractive secular growth potential.
This article was written by a staff member of TheStreet.